WADA launches online application system for Anti-Doping organizations to apply for flexibility in the implementation of the technical document for sport specific analysis (TDSSA) minimum levels of analysis
The World Anti-Doping Agency (WADA) is pleased to announce that – further to the amendments made to the Technical Document for Sport Specific Analysis (TDSSA) following the stakeholder consultation process conducted in 2019 – it has developed an online application system for Anti-Doping Organizations (ADOs) to apply for flexibility in the implementation of the Minimum Levels of Analysis (MLAs) for the sports and disciplines contained within the TDSSA.
An ADO can qualify for flexibility in the implementation of the TDSSA MLAs based on the following two scenarios:
- The implementation of a haematological module of the Athlete Biological Passport (ABP); and
- Other non-ABP related criteria e.g. prioritization of target testing, collaboration with other ADOs, use of intelligence in the implementation of an ADO’s anti-doping program, etc*.
The application process is located within the Code Compliance Center (CCC – previously the Code Compliance Questionnaire) platform through which ADOs are required to answer a number of questions against set criteria (listed in Article 6 of the TDSSA) as well as upload supporting documents – including their Risk Assessments, Test Distribution Plans and Registered Testing Pools. On completion of the application, and based on the answers to the questions, ADOs will receive a pre-approved level of flexibility (up to a maximum of 50%) for the implementation of the MLAs for the sports or disciplines they seek flexibility for. This pre-approved flexibility is subject to review by WADA.
ADOs that are interested in applying for flexibility in the implementation of the MLAs should contact WADA to outline their intentions at firstname.lastname@example.org. WADA will subsequently open access to the online application by sending an “Invitation Notification” to interested ADOs. For more information, ADOs are encouraged to read the Application for Flexibility User Guide before contacting WADA.
Revised TDSSA Testing Guides
To further support implementation of version 5.0 of the TDSSA, WADA would like to remind ADOs to utilize the updated Testing Guides for Erythropoiesis Stimulating Agents (ESAs), Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs). ADOs are encouraged to consult these Guides to support their testing strategies when applying analysis for these categories of substances within the scope of the TDSSA.
Should you have any questions relating to the above, please do not hesitate to contact email@example.com.
World Anti-Doping Agency